Sergio Gutiérrez‐Ureña

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

Dae‐Hyun Yoo, Paweł Hrycaj, Pedro C. Miranda et al. · Annals of the Rheumatic Diseases · 2013 · 653 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Won Park, Paweł Hrycaj, Volodymyr Kovalenko et al. · Annals of the Rheumatic Diseases · 2013 · 604 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

John S. Sundy, Herbert S. B. Baraf, Robert A. Yood et al. · JAMA · 2011 · 516 citations · Full text

Pharmacy, Pharmacotherapy, Biopharmaceutics +14

Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis

Sergio Gutiérrez‐Ureña, José Fernando Molina, M L Cuéllar et al. · Arthritis & Rheumatism · 1996 · 280 citations

Medicine, Pharmacology, Pharmacotherapy +11

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Won Park, Dae‐Hyun Yoo, Pedro C. Miranda et al. · Annals of the Rheumatic Diseases · 2016 · 229 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13